Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

, BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

19:05
09/16/19
09/16
19:05
09/16/19
19:05

Fly Intel: After Hours Movers

HIGHER: Aclaris Therapeutics (ACRS) up 45.5% after its Phase 3 clinical trial of A-101 45% Topical Solution for treatment of common warts met all endpoints. DOWN AFTER EARNINGS: Concrete Pumping (BBCP) down 9.0%. ALSO LOWER: Corning (GLW) down 8.5% after cutting Q3 volume forecasts in Display and Optical Communications units... Acceleron (XLRN) down 7.8% after disclosing its ACE-083 trial did not meet secondary endpoints... Shopify (SHOP) down 4.6% after filing to sell 1.9M subordinate shares... Kraft Heinz (KHC) down 2.7% after private equity investor 3G Capital sold 25.1M share stake... Plus Therapeutics (PSTV) down 2.3% after filing mixed securities shelf... Movers as of 18:45ET.

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

GLW

Corning

$30.04

-0.12 (-0.40%)

XLRN

Acceleron

$44.67

0.75 (1.71%)

SHOP

Shopify

$337.93

-0.77 (-0.23%)

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

PSTV

Plus Therapeutics

$9.51

-0.05 (-0.52%)

  • 16

    Sep

  • 18

    Sep

  • 01

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

  • 17

    Sep

ACRS Aclaris Therapeutics
$1.09

0.06 (5.83%)

08/09/19
CANT
08/09/19
NO CHANGE
Target $5
CANT
Overweight
Aclaris Therapeutics price target lowered to $5 from $24 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen lowered her price target for Aclaris Therapeutics to $5 from $24 to reflect downward earnings revisions post the company's Q2 results. The analyst, however, still thinks there is value to be unlocked in Rhofade and Aclaris' pipeline. As such, she expects multiple expansion to drive shares higher as "this is realized through solid execution." Chen reiterates an Overweight rating on Aclaris Therapeutics.
09/06/19
09/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Antero Resources (AR) downgraded to Neutral from Buy at Goldman Sachs with analyst Brian Singer saying the stock offers a less attractive relative valuation at 5.5-times his expected FY20 upstream pre-hedge EBITDA, which is largely in line with its other "gassy" peers. 2. Bank of America (BAC) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying that following the Federal Reserve's recent rate cut, the trade war escalated, which is now expected to lower economic growth. 3. Conagra Brands (CAG) downgraded to Neutral from Buy at Goldman Sachs with analyst Jason English saying consensus estimates for sales and earnings may be too high in the near term. 4. Aclaris Therapeutics (ACRS) downgraded to Market Perform from Outperform at JMP Securities with analyst Donald Ellis citing the company's announcement that it is reviewing strategic alternatives and laying off staff yesterday. 5. Entergy (ETR) downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/19
09/06/19
DOWNGRADE

Market Perform
Aclaris Therapeutics cut to Market Perform at JMP Securities on strategic review
As previously reported, JMP Securities analyst Donald Ellis downgraded Aclaris Therapeutics to Market Perform from Outperform after the company announced that it is reviewing strategic alternatives and laying off staff yesterday. The analyst notes that while the stock is trading at a near cash per share valuation, it has also shifted its focus to developing early-stage assets in rheumatology and immuno-inflammatory conditions and has no clinical trial data yet from these programs yet. Ellis expects Aclaris to spend about $33M over the next 12 months, leaving it with $62M in cash.
09/06/19
JMPS
09/06/19
DOWNGRADE
JMPS
Market Perform
Aclaris Therapeutics downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Donald Ellis downgraded Aclaris Therapeutics to Market Perform from Outperform.
BBCP Concrete Pumping
$4.40

0.265 (6.41%)

05/17/19
WBLR
05/17/19
INITIATION
WBLR
Outperform
Concrete Pumping initiated with an Outperform at William Blair
William Blair analyst Tim Mulrooney started Concrete Pumping Holdings with an Outperform rating saying the company is the market leader in concrete pumping services.
05/17/19
WBLR
05/17/19
INITIATION
WBLR
Outperform
William Blair starts 'market leader' Concrete Pumping with Outperform rating
William Blair analyst Tim Mulrooney initiated coverage of Concrete Pumping Holdings with an Outperform rating. Concrete pumping is a faster and safer alternative to traditional techniques such as tailgating, particularly in urban environments, Mulrooney tells investors in a research note. The analyst expects concrete pumping to continue to take share from traditional placement techniques, driven by secular tailwinds such as urbanization and labor availability, and he views Concrete Pumping as the market leader. He views the stock's current risk/reward profile as favorable.
05/23/19
STFL
05/23/19
INITIATION
Target $9
STFL
Buy
Concrete Pumping initiated with a Buy at Stifel
Stifel analyst Stanley Elliott started Concrete Pumping Holdings with a Buy rating and $9 price target. The company has "meaningful opportunity" to expand through "mild" secular growth in concrete pumping, footprint expansion and cross-selling of waste services, and numerous acquisition roll-up opportunities, says the analyst. He believes the stock trades at an attractive multiple.
05/17/19
05/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twitter (TWTR) initiated with an Equal Weight at Consumer Edge. 2. Wayfair (W) initiated with a Buy at Jefferies. 3. Kontoor Brands (KTB) initiated with a Neutral at Goldman Sachs whyle VF Corp. (VFC) post-spin shares were initiated with Buy at Goldman Sachs. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at UBS. 5. Concrete Pumping (BBCP) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
GLW Corning
$30.04

-0.12 (-0.40%)

08/01/19
08/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Prudential (PRU) downgraded to Neutral from Buy at B. Riley FBR with analyst Randy Binner citing the company's Q2 results. 2. SBA Communications (SBAC) downgraded to Neutral from Overweight at JPMorgan. 3. Air Products (APD) downgraded to Hold from Buy at HSBC with analyst Sriharsha Pappu citing valuation for the downgrade. 4. T2 Biosystems (TTOO) downgraded to Neutral from Buy at Alliance Global Partners. 5. Corning (GLW) downgraded to Neutral from Positive at Susquehanna with analyst Mehdi Hosseini downgraded Corning (GLW) to Neutral from Positive with analyst Mehdi Hosseini saying he moved to the sidelines until he is convinced earnings and CAGR can exceed the earnings from the S&P500. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/19
SUSQ
08/01/19
DOWNGRADE
Target $30
SUSQ
Neutral
Corning downgraded to Neutral at Susquehanna
As reported previously, Susquehanna analyst Mehdi Hosseini downgraded Corning to Neutral from Positive. The analyst moved to the sidelines until he is convinced earnings and CAGR can exceed the earnings from the S&P500. He said until then, he cannot justify its premium valuation because he feels the company has recently failed to execute in managing its portfolio of diverse business units. Hosseini lowered his price target to $30 from $40 on Corning shares.
08/08/19
08/08/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Apple (AAPL), Samsung (SSNLF), HP Enterprise (HPE), HP Inc. (HPQ), and Dell Technologies (DELL) initiated with an Equal Weight at Barclays. 2. Avalara (AVLR) initiated with an Outperform at William Blair. 3. BlueLinx (BXC) initiated with a Buy at B. Riley FBR. 4. Corning (GLW) initiated with an Overweight at Barclays while Seagate (STX) was initiated with an Underweight, and Western Digital (WDC) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/19
LEHM
08/07/19
INITIATION
Target $35
LEHM
Overweight
Corning initiated with an Overweight at Barclays
Barclays analyst Tim Long initiated Corning with an Overweight rating and a price target of $35. The analyst says the Optical Communications sector is set to grow by over 5% over the next 2-3 years thanks to the development of 5G and data center trends, noting that the performance may be lumpy, but overall growth should be "solid" for several years. Long adds that Corning is adding to capacity to support increased demand. The analyst also points to greater penetration of dual-sided Gorilla Glass offsetting the flat market for handsets and sees potential for Corning's automotive glass to make a "meaningful" contribution to backlog as the new dedicated plant starts operations in Q3.
XLRN Acceleron
$44.67

0.75 (1.71%)

05/10/19
HCWC
05/10/19
NO CHANGE
HCWC
Acceleron price target raised to $69 from $66 at H.C. Wainwright
H.C. Wainwright analyst Edward White maintained a Buy rating on Acceleron Pharma and raised his price target on shares to $69 from $66 after the company reported Q1 results. The analyst noted he continues to expect "approval and commercial success for luspatercept" and sees luspatercept sales totalling $164M in 2020, implying $32.8M in royalties for Acceleron.
09/06/19
HCWC
09/06/19
NO CHANGE
Target $69
HCWC
Buy
H.C. Wainwright backs Buy rating on Acceleron after sotatercept gets ODD
H.C. Wainwright analyst Edward White maintained a Buy rating and $69 price target on Acceleron Pharma after sotatercept received orphan drug designation from the FDA for the treatment of patients with pulmonary arterial hypertension. In a research note to investors, White says Acceleron is evaluating sotatercept in PAH patients in the randomized, double blind, placebo-controlled PULSAR Phase 2 trial, which is assessing sotatercept plus standard of care versus placebo plus SoC in participants with PAH of WHO Group 1, functional class II-III. White says topline results for the PULSAR trial are expected in the first quarter of 2020, while the Phase 2 SPECTRA exploratory trial in adult PAH patients that receive SoC plus sotatercept for a 24 week treatment period followed by a 16 week follow up period is enrolling and is expected to have preliminary results in 2020.
05/24/19
SBSH
05/24/19
INITIATION
Target $66
SBSH
Buy
Citi assumes Acceleron at Buy, sees 'significant' upside potential
Citi analyst Yigal Nochomovitz assumed coverage of Acceleron Pharma with a Buy rating and boosted his price target for the shares to $66 from $63. The analyst sees potential for "significant" share upside over the next 12-18 months with lead drug Luspatercept launching in early 2020, catalysts from Luspatercept expansion and an evolving pipeline.
05/29/19
GSCO
05/29/19
INITIATION
Target $54
GSCO
Neutral
Acceleron assumed with a Neutral at Goldman Sachs
Goldman Sachs analyst Paul Choi assumed coverage of Acceleron Pharma with a Neutral rating and $54 price target. Prior analyst Terence Flynn had a Neutral rating on the shares with a $40 price target. Choi believes the launch of luspatercept will be the primary driver of stock performance over the next 12 months, and his estimates are broadly in-line with the consensus.
SHOP Shopify
$337.93

-0.77 (-0.23%)

09/10/19
JEFF
09/10/19
NO CHANGE
Target $300
JEFF
Hold
Shopify acquisition expands total addressable market, says Jefferies
While the financial impact of Shopify's 6 River Systems acquisition is minimal in the near-term, the deal accelerates the company's ambitions to build out a fulfillment network and expands the total addressable market, Jefferies analyst Samad Samana tells investors in a research note. In addition to the acquired technology, the analyst also views folding in 6 River's leadership as valuable to Shopify, noting two formerly served in leadership roles at Amazon. Samana keeps a Hold rating on Shopify with a $300 price target.
09/10/19
PIPR
09/10/19
NO CHANGE
Target $320
PIPR
Neutral
Shopify acquisition positive for fulfillment scale, says Piper Jaffray
Piper Jaffray analyst Michael Olson believes Shopify's acquisition of 6 River is a positive for the company's ability to more rapidly scale its fulfillment network. Shopify management was likely weighing the balance between internally building out similar fulfillment solutions, but opted to buy versus build in order to accelerate the trajectory of its offering, Olson tells investors in a research note. The analyst keeps a Neutral rating on Shopify shares with a $320 price target based on valuation.
09/09/19
BARD
09/09/19
NO CHANGE
Target $410
BARD
Outperform
Shopify price target raised to $410 from $370 at Baird
Baird analyst Colin Sebastian raised his price target on Shopify to $410 from $370 as he remains constructive on the company given ongoing favorable secular e-commerce trends, large online services market opportunity, mission critical software offering, and incremental monetization opportunities. Sebastian reiterated his Outperform rating on Shopify shares.
09/11/19
ADAM
09/11/19
NO CHANGE
Target $385
ADAM
Buy
Shopify acquisition accelerates its fulfillment strategy, says Canaccord
Canaccord analyst David Hynes noted Shopify announced intentions to acquire 6 River Systems, a provider of warehouse automation technology. The analyst said the acquisition accelerates its fulfillment strategy and he would be a buyer on any pullbacks. Hynes reiterated his Buy rating and $385 price target on Shopify shares.
KHC Kraft Heinz
$29.62

0.37 (1.27%)

08/09/19
GUGG
08/09/19
DOWNGRADE
Target $25
GUGG
Sell
Kraft Heinz downgraded to Sell from Neutral at Guggenheim
Guggenheim analyst Laurent Grandet downgraded Kraft Heinz to Sell from Neutral and lowered her price target for the shares to $25 from $29. The "new negative news" from yesterday's results is that the situation won't likely start to improve until next year at the earliest since new CEO Miguel Patricio's plan won't be implemented until early 2020, Grandet tells investors in a research note. The analyst continues to think that Patricio faces a "monumental challenge" to put Kraft Heinz on a path to success.
08/12/19
BMOC
08/12/19
NO CHANGE
Target $33
BMOC
Market Perform
Kraft Heinz price target lowered to $33 from $40 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Kraft Heinz to $33 and kept his Market Perform rating after its Q1 earnings miss driven by retail inventory destocking, higher fixed cost spending, and an inflationary input environment. The analyst also cites the company's disclosed $744M in impairment charges on its EMEA East, Brazil, US Refrigerated, and Latin America exports businesses along with the CEO's plans to undertake a "strategic agenda" early next year, even though the management has indicated that the dividend payout on the stock is safe.
08/08/19
JPMS
08/08/19
NO CHANGE
JPMS
Neutral
Kraft Heinz earnings call 'raised more questions than answers,' says JPMorgan
JPMorgan analyst Ken Goldman lowered his estimates for Kraft Heinz following the company's first earnings call in six months, stating that "the call raised more questions than answers." While management made it clear, in his view, that a major margin rebase is not part of its plan, restraint on divestitures doesn't help reduce near-term leverage and "Street forecasts are almost surely going to drop," Goldman tells investors in a post-earnings research note. He does not think a downgrade is warranted with the stock trading at a "very low multiple," but neither can he recommend Kraft Heinz shares until there is more clarity on the strategy and opportunities, said Goldman, who keeps a Neutral rating on the stock.
08/09/19
08/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Maximus (MMS) downgraded to Market Perform from Outperform at Wells Fargo. 2. Cardlytics (CDLX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Andy Hargreaves saying its Q2 results showed "solid momentum" in both MAU and ARPU even though the FY19 outlook was disappointing. 3. Coeur Mining (CDE) downgraded to Hold from Buy at Canaccord. 4. Kraft Heinz (KHC) downgraded to Sell from Neutral at Guggenheim with analyst Laurent Grandet saying the "new negative news" from yesterday's results is that the situation won't likely start to improve until next year at the earliest since new CEO Miguel Patricio's plan won't be implemented until early 2020. 5. Synaptics (SYNA) downgraded to Underweight from Neutral at JPMorgan and to Hold from Buy at Craig-Hallum. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PSTV Plus Therapeutics
$9.51

-0.05 (-0.52%)

TODAY'S FREE FLY STORIES

NIO

NIO Inc.

$1.48

0.01 (0.68%)

10:10
10/18/19
10/18
10:10
10/18/19
10:10
Options
Nov 1.5 put seller in NIO cashes out 140% winner »

Nov 1.5 put seller in NIO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRET

Investors Real Estate

$76.60

0.75 (0.99%)

, PINS

Pinterest

$25.86

-0.14 (-0.54%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

IRET

Investors Real Estate

$76.60

0.75 (0.99%)

PINS

Pinterest

$25.86

-0.14 (-0.54%)

SNAP

Snap

$14.00

0.22 (1.60%)

IDN

Intellicheck

$5.00

(0.00%)

WBT

Welbilt

$17.97

(0.00%)

DAVA

Endava

$40.06

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 05

    Nov

  • 07

    Nov

  • 11

    Nov

  • 12

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 04

    Dec

  • 05

    Dec

  • 16

    Oct

GIL

Gildan Activewear

$25.88

-9.495 (-26.84%)

, CAT

Caterpillar

$131.37

1.36 (1.05%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

GIL

Gildan Activewear

$25.88

-9.495 (-26.84%)

CAT

Caterpillar

$131.37

1.36 (1.05%)

CRL

Charles River

$135.10

-0.97 (-0.71%)

M

Macy's

$14.98

-0.79 (-5.01%)

LB

L Brands

$16.56

-1.54 (-8.51%)

GPS

Gap

$16.53

-1.05 (-5.97%)

WM

Waste Management

$115.34

-0.97 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 31

    Oct

  • 04

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

MO

Altria Group

$44.40

0.14 (0.32%)

, SNAP

Snap

$13.99

0.21 (1.52%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MO

Altria Group

$44.40

0.14 (0.32%)

SNAP

Snap

$13.99

0.21 (1.52%)

CMG

Chipotle

$846.04

17.95 (2.17%)

RSG

Republic Services

$87.30

1.15 (1.33%)

WCN

Waste Connections

$92.97

0.7 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 12

    Nov

STT

State Street

$60.83

1.12 (1.88%)

10:05
10/18/19
10/18
10:05
10/18/19
10:05
Hot Stocks
State Street says reigniting servicing fee revenue growth remains a top priority »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

10:02
10/18/19
10/18
10:02
10/18/19
10:02
General news
Leading Indicators data reported »

September Leading…

SXT

Sensient

$60.60

-5.97 (-8.97%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Sensient falls -8.8% »

Sensient is down -8.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NNA

Navios Acquisition

$8.58

-1.78 (-17.18%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Navios Acquisition falls -17.6% »

Navios Acquisition is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIL

Gildan Activewear

$26.26

-9.12 (-25.78%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Gildan Activewear falls -25.8% »

Gildan Activewear is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

X

U.S. Steel

$10.67

0.05 (0.47%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Options
Size put buyer in US Steel March 8 strike »

Size put buyer in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$22.40

1.13 (5.31%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Holly Energy Partners rises 5.3% »

Holly Energy Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KSU

Kansas City Southern

$143.50

8.17 (6.04%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Kansas City Southern rises 6.0% »

Kansas City Southern is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 13

    Nov

BORR

Borr Drilling

$6.57

0.53 (8.77%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Borr Drilling rises 9.7% »

Borr Drilling is up 9.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIL

Gildan Activewear

$26.54

-8.835 (-24.98%)

09:59
10/18/19
10/18
09:59
10/18/19
09:59
Downgrade
Gildan Activewear rating change  »

BofA/Merrill double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

JNJ

Johnson & Johnson

$132.71

-3.49 (-2.56%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Options
Johnson & Johnson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PBCT

People's United

$16.17

0.41 (2.60%)

, KSU

Kansas City Southern

$141.65

6.32 (4.67%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Options
Early notable gainers among liquid option names on October 18th »

Notable gainers among…

PBCT

People's United

$16.17

0.41 (2.60%)

KSU

Kansas City Southern

$141.65

6.32 (4.67%)

APA

Apache

$23.24

1.12 (5.06%)

ETFC

E-Trade

$40.84

1.8 (4.61%)

ISRG

Intuitive Surgical

$552.97

23.75 (4.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 27

    Oct

  • 31

    Oct

  • 13

    Nov

AMZN

Amazon.com

$1,785.24

-2.6 (-0.15%)

, MSFT

Microsoft

$139.65

-0.03 (-0.02%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Conference/Events
Deutsche Bank TMT analyst to hold an analyst/industry conference call »

Tech, Media & Telecom…

AMZN

Amazon.com

$1,785.24

-2.6 (-0.15%)

MSFT

Microsoft

$139.65

-0.03 (-0.02%)

GOOG

Alphabet

$1,256.30

3.51 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

CRM

Salesforce

$145.81

-0.36 (-0.25%)

09:50
10/18/19
10/18
09:50
10/18/19
09:50
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

The Economic Club of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

MRK

Merck

$84.14

0.34 (0.41%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Recommendations
Merck analyst commentary  »

Merck's Keytruda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

NNA

Navios Acquisition

$8.51

-1.85 (-17.86%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Navios Acquisition falls -18.3% »

Navios Acquisition is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$60.60

-5.97 (-8.97%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Sensient falls -10.7% »

Sensient is down -10.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GIL

Gildan Activewear

$24.14

-11.235 (-31.76%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Gildan Activewear falls -31.1% »

Gildan Activewear is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
On The Fly
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

FB

Facebook

$190.85

0.46 (0.24%)

V

Visa

$177.86

-0.08 (-0.04%)

MA

MasterCard

$275.62

-1.02 (-0.37%)

PYPL

PayPal

$103.98

0.35 (0.34%)

BKNG

Booking Holdings

$2,024.24

-4.39 (-0.22%)

EBAY

eBay

$39.12

-0.01 (-0.03%)

JPM

JPMorgan

$120.18

-0.21 (-0.17%)

GS

Goldman Sachs

$205.75

-0.735 (-0.36%)

OSTK

Overstock.com

$11.29

-0.03 (-0.27%)

SRAX

Social Reality

$2.05

(0.00%)

AMD

AMD

$31.08

-0.08 (-0.26%)

NVDA

Nvidia

$194.48

0.19 (0.10%)

DPW

DPW Holdings

$1.68

(0.00%)

KODK

Kodak

$2.41

(0.00%)

RIOT

Riot Blockchain

$1.72

(0.00%)

IDEX

Ideanomics

$1.39

(0.00%)

TEUM

Pareteum

$0.83

0.0044 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 20

    Nov

  • 14

    Jan

KSU

Kansas City Southern

$141.52

6.19 (4.57%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Kansas City Southern rises 4.4% »

Kansas City Southern is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 13

    Nov

RNGR

Ranger Energy

$5.83

-0.16 (-2.67%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Ranger Energy rises 6.7% »

Ranger Energy is up 6.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.